Search Within

Department of Medicine

Formats
  1. Journal Article (19618)
  2. Meeting Abstract (16046)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22348)
  2. Hematologic Malignancies, Division of (13287)
  3. Center for Hematologic Malignancies (11069)
  4. GSK Faculty (10653)
  5. Survivorship Research (9346)
  6. Division of Subspecialty Medicine (7554)

More Groups

People
  1. Robert Motzer (1249)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1118)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2291)
  6. Nature Publishing Group (2121)

More Publishers

Results (39669)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High dose Busulfan and fFludarabine with anti-thymocyte globulin (ATG) followed by unmodified marrow grafts from HLA-matched siblings for the treatment of high risk hemoglobinopathies (HGBpathies)
    Meeting Abstract

    Boulad, F.; Kernan, N. A.; Small, T. N.; Chewning, J.; Prockop, S.; Scaradavou, A.; Keating, A.; O'Reilly, R. J.
    Blood (2005)

    Fulltext@MSK | Save
  • Phase I/II study of the anti-CD30 antibody MDX-060 in patients with refractory/relapsed CD30 positive lymphoma
    Meeting Abstract

    Borchmann, P.; Ansell, S.; Byrd, J.; Horwitz, S.; Strair, R.; Khan, K.; Fischkoff, S.; Yellin, M.; Engert, A.
    Annals of Oncology (2005)

    Fulltext@MSK | Save
  • Prognosis after androgen deprivation therapy in men with a rising PSA after prostatectomy
    Meeting Abstract

    Bianco, F. J.; Kattan, M. W.; Beekman, K. W.; Scher, H. I.; Scardino, P. T.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Confocal reflectance imaging of pigmented skin lesions in vivo: Initial steps towards a terminology consensus
    Meeting Abstract

    Benvenuto-Andrade, C.; Agero, A. L.; Dusza, S.; Rajadhyaksha, M.; Busam, K.; Marra, D.; Torres, A.; Propperova, I.; Langley, R.; Marghoob, A.; more...
    Journal of Investigative Dermatology (2005)

    Fulltext@MSK | Save
  • Clinical correlation of EUS with pathologic stage and outcome in patients undergoing a curative resection for gastric cancer
    Meeting Abstract

    Bentrem, D.; Gerdes, H.; Brennan, M.; Coit, D.
    Annals of Surgical Oncology (2005)

    Fulltext@MSK | Save
  • Stage specific survival is altered by the changes in the 2002 AJCC staging for melanoma
    Meeting Abstract

    Ben-Porat, L.; Panageas, K. S.; Hanlon, C.; Patel, A.; Houghton, A. N.; Halpern, A. C.; Coit, D. G.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Outcomes with second-line chemotherapy in castrate metastatic prostate cancer
    Meeting Abstract

    Beekman, K. W.; Fleming, M. T.; Scher, H. I.; Warren, M.; Ishill, N.; Heller, G.; Kelly, W. K.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Patient reported outcomes in a phase 2 trial of SU11248 for metastatic renal cell carcinoma
    Meeting Abstract

    Beaumont, J.; Cella, D.; Li, J.; Motzer, R.; Rini, B.; Michaelson, D.; Kim, S.; Baum, C.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • SWOG/intergroup 9623: A phase III comparison of intensive sequential chemotherapy to high dose chemotherapy and autologous hematopoietic progenitor cell support (AHPCS) for primary breast cancer in women with >= 4 involved axillary lymph nodes
    Meeting Abstract

    Bearman, S. I.; Green, S.; Gralow, J.; Barlow, W.; Hudis, C.; Wolff, A.; Ingle, J.; Hortobagyi, G.; Livingston, R.; Martino, S.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Patient online self-reporting of toxicity symptoms during chemotherapy
    Meeting Abstract

    Basch, E. M.; Dulko, D.; Artz, D.; Scher, K.; Sabbatini, P.; Hensley, M.; Mitra, N.; Speakman, J.; McCabe, M.; Schrag, D.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save